Neovascular age-related macular degeneration (nAMD) is a progressive eye disease characterized by choroidal ...

PackGene is a world-leading Adeno-Associated Virus (AAV) vector CRO and CDMO company, providing economical, reliable, and scalable plasmid DNA and AAV viral vector production for early-stage drug ...

Recent clinical trials utilizing high doses of adeno-associated virus (AAV) vectors have highlighted a new challenge to AAV gene transfer—activation of the complement system. A new article in ...

The global adeno associated virus vector manufacturing market size is expected to reach USD 3.95 billion by 2030, registering a CAGR of 22.5% over the forecast period.

Treatment with fidanacogene elaparvovec, a recombinant adeno-associated virus (AAV) vector developed for the treatment of hemophilia B, led to sustained expression of the high-activity factor IX va ...

Title: An Extended Kinetic Study of AAV Viral Vector Production Presenters: Daniel Brownell and Lucia Fernandez, PhD Session Date/Time: May 15, 2025, 5:30 PM - 7:00 PM ...

DelveInsight’s, “ Gene Therapy Competitive landscape, 2025 ,” report provides comprehensive insights about 180+ companies and ...

The "Adeno-Associated Virus (AAV) Vectors in Gene Therapy – Market Insight, Epidemiology and Market Forecast – 2030" drug pipelines has been added to ResearchAndMarkets.com’s offering. This ...

Researchers have developed an engineered adeno-associated virus (AAV) vector that yields high transduction of brain vascular pericytes and smooth muscle cells. The study describing the ...

News Adeno-associated virus Cell culture DNA Gene therapy (Therapeutics) Viral vector (Applied microbiology) Cytiva ...